Roquette Pharma Denmark ApS: Financial statements 2025
CVR: 45239128
Source: annual report 2025, Danish Business Authority
28/11/2024 – 31/12/2025
Roquette Pharma Denmark ApS (CVR 45239128) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,610,420 and a net result of DKK 139,866. Equity in the 2025 report amounted to DKK 179,866. The solvency ratio was 13%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 4,610,420
- Profit/Loss
- DKK 139,866
- Equity
- DKK 179,866
- Total Assets
- DKK 1,384,444
- Employees
- 3
Official annual report
How creditworthy is Roquette Pharma Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
On January 21, 2025, the company changed its name from ROQUETTE PHARMA ApS to Roquette Pharma Denmark ApS.
About Roquette Pharma Denmark ApS
Roquette Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named ROQUETTE PHARMA ApS. The management consists of Delphine DESRUMAUX. The company is owned by ROQUETTE HEALTH & PHARMA SOLUTIONS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 4,610,420 and a net result of DKK 139,866. Equity in the 2025 report amounted to DKK 179,866.